A single-institution validation of the AJCC staging system for stage IV melanoma Academic Article uri icon

Overview

MeSH Major

  • Melanoma

abstract

  • In our patient cohort, the AJCC staging system was valid. The strongest predictor of survival-the number of metastases present at the diagnosis of stage IV disease-represents a variable to consider in future staging systems.

publication date

  • July 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1245/s10434-008-9915-0

PubMed ID

  • 18465172

Additional Document Info

start page

  • 2034

end page

  • 41

volume

  • 15

number

  • 7